Merck & Co.'s allergy drug Singulair. JB Reed | Bloomberg | Getty Images U.S. government researchers have fou…
The results position the company to seek an expanded approval of its therapy, Caplyta, in the second half of the year. …
By Amanda Saionz Chinese player Legend Biotech reached a new turning point last month when its Johnson & Johnson-p…